Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Evertec | EVTC | Nov 15, 2024 | 34.64 | +0.55 |
Everus Construction Group, Inc. When Issued | ECG | Nov 15, 2024 | 56.34 | 0.00 |
EVgo | EVGO | Nov 15, 2024 | 5.06 | +0.20 |
EVI Industries | EVI | Nov 15, 2024 | 17.97 | -2.55 |
Evogene | EVGN | Nov 15, 2024 | 1.73 | -1.14 |
Evoke Pharma | EVOK | Nov 15, 2024 | 4.58 | +4.91 |
Evolent Health A | EVH | Nov 15, 2024 | 12.38 | -2.29 |
Evolus | EOLS | Nov 15, 2024 | 12.11 | +1.94 |
Evolution Petroleum | EPM | Nov 15, 2024 | 5.84 | -0.17 |
Evolv Technologies A | EVLV | Nov 15, 2024 | 2.58 | +2.79 |
Evotec ADR | EVO | Nov 15, 2024 | 5.44 | +6.67 |
Exact Sciences | EXAS | Nov 15, 2024 | 49.33 | -3.14 |
Exagen | XGN | Nov 15, 2024 | 2.98 | +2.76 |
Excelerate Energy | EE | Nov 15, 2024 | 27.54 | -0.15 |
ExcelFin Acquisition A | XFIN | Nov 15, 2024 | 9.24 | 0.00 |
Exela Technologies | XELA | Nov 15, 2024 | 1.98 | 0.00 |
Exela Technologies B Pref | XELAP | Nov 15, 2024 | 1.23 | 0.00 |
Exelixis | EXEL | Nov 15, 2024 | 34.45 | -1.71 |
Exelon | EXC | Nov 15, 2024 | 39.11 | +2.60 |
Exicure | XCUR | Nov 15, 2024 | 2.90 | -8.81 |
ExlService | EXLS | Nov 15, 2024 | 44.69 | -1.61 |
eXp World | EXPI | Nov 15, 2024 | 13.31 | -1.84 |
Expand Energy | EXE | Nov 15, 2024 | 94.99 | 0.00 |
Expedia | EXPE | Nov 15, 2024 | 181.35 | -0.50 |
Expeditors International of Washington | EXPD | Nov 15, 2024 | 120.16 | -0.66 |
Expensify A | EXFY | Nov 15, 2024 | 2.75 | -3.85 |
Expion360 | XPON | Nov 15, 2024 | 2.60 | -24.64 |
Exponent | EXPO | Nov 15, 2024 | 97.40 | -1.23 |
Expro | XPRO | Nov 15, 2024 | 12.70 | -4.22 |
Exscientia ADR | EXAI | Nov 15, 2024 | 4.69 | -11.68 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.